Fiscal year 2026 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses TRNS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TRNS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Lee Rudow | $737,000 | $0 | $4,613,932 | $0 | $494,115 | $0 | $17,153 | $5,862,200 |
| Former President and Chief Executive Officer | ||||||||
| Thomas Barbato | 396,000 | 0 | 1,695,231 | 0 | 132,544 | 0 | 11,625 | 2,235,400 |
| Chief Financial Officer and Treasurer | ||||||||
| Michael West | 363,000 | 0 | 966,521 | 0 | 97,408 | 0 | 11,617 | 1,438,546 |
| Chief Operating Officer | ||||||||
| Theresa Conroy | 311,000 | 0 | 832,082 | 0 | 83,214 | 0 | 10,294 | 1,236,590 |
| Chief Human Resources Officer | ||||||||
| Michael Haddad | 312,000 | 0 | 502,099 | 0 | 83,492 | 0 | 9,922 | 907,513 |
| Chief Information Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Lee Rudow | $5,862,200 | $1,815,360 | $2,440,460 | +4,046,840 |
| Thomas Barbato | 2,235,400 | 922,852 | 994,829 | +1,312,548 |
| Michael West | 1,438,546 | 848,869 | 619,363 | +589,677 |
| Theresa Conroy | 1,236,590 | 536,039 | 596,967 | +700,551 |
| Michael Haddad | 907,513 | 367,727 | — | +539,786 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Michael Haddad | RSU | 2026-01-06 | — | — | 5,190 | — | $314,981 |
| Theresa Conroy | RSU | 2026-01-06 | — | — | 10,380 | — | 629,962 |
| Lee Rudow | RSU | 2025-08-21 | — | — | 14,782 | — | 1,249,966 |
| Michael West | RSU | 2026-01-06 | — | — | 12,028 | — | 729,979 |
| Lee Rudow | RSU | 2025-08-21 | — | — | 12,500 | — | 1,057,000 |
| Lee Rudow | PSU | 2025-08-21 | 6,250 | 12,500 | — | 18,750 | 1,057,000 |
| Theresa Conroy | PSU | 2025-05-27 | 549 | 1,098 | — | 1,647 | 101,060 |
| Thomas Barbato | RSU | 2026-01-06 | — | — | 19,772 | — | 1,199,963 |
| Michael West | RSU | 2025-05-27 | — | — | 1,285 | — | 118,271 |
| Thomas Barbato | RSU | 2025-05-27 | — | — | 2,691 | — | 247,680 |
| Michael West | PSU | 2025-05-27 | 643 | 1,285 | — | 1,928 | 118,271 |
| Thomas Barbato | PSU | 2025-05-27 | 1,345 | 2,690 | — | 4,035 | 247,588 |
| Michael Haddad | RSU | 2025-05-27 | — | — | 1,017 | — | 93,605 |
| Michael Haddad | PSU | 2025-05-27 | 508 | 1,016 | — | 1,524 | 93,513 |
| Theresa Conroy | RSU | 2025-05-27 | — | — | 1,098 | — | 101,060 |
| Lee Rudow | PSU | 2025-08-21 | 7,391 | 14,782 | — | 22,173 | 1,249,966 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Michael Haddad | $408,586 | $93,513 | $0 | 18.6% |
| Theresa Conroy | 731,022 | 101,060 | 0 | 12.1% |
| Lee Rudow | 2,306,966 | 2,306,966 | 0 | 50.0% |
| Michael West | 848,250 | 118,271 | 0 | 12.2% |
| Thomas Barbato | 1,447,643 | 247,588 | 0 | 14.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Michael West | PSU | 725 | — | $51,707 |
| Thomas Barbato | RSU | 19,772 | — | 1,410,139 |
| Theresa Conroy | RSU | 1,098 | — | 78,309 |
| Lee Rudow | PSU | 3,784 | — | 269,875 |
| Lee Rudow | PSU | 14,782 | — | 1,054,252 |
| Michael Haddad | RSU | 730 | — | 52,064 |
| Theresa Conroy | RSU | 783 | — | 55,844 |
| Michael West | PSU | 1,285 | — | 91,718 |
| Lee Rudow | PSU | 12,500 | — | 891,500 |
| Theresa Conroy | PSU | 782 | — | 55,772 |
| Thomas Barbato | PSU | 1,918 | — | 136,792 |
| Thomas Barbato | RSU | 2,691 | — | 191,922 |
| Michael West | PSU | 916 | — | 65,329 |
| Michael Haddad | RSU | 5,190 | — | 370,151 |
| Thomas Barbato | PSU | 2,690 | — | 191,922 |
| Thomas Barbato | RSU | 1,919 | — | 136,863 |
| Michael West | RSU | 12,028 | — | 857,837 |
| Michael Haddad | RSU | 1,017 | — | 72,532 |
| Michael Haddad | PSU | 1,016 | — | 72,532 |
| Theresa Conroy | PSU | 1,098 | — | 78,309 |
| Michael West | RSU | 1,285 | — | 91,718 |
| Lee Rudow | RSU | 14,782 | — | 1,054,252 |
| Theresa Conroy | RSU | 10,380 | — | 740,302 |
| Lee Rudow | RSU | 3,925 | — | 279,931 |
| Lee Rudow | RSU | 8,333 | — | 594,310 |
| Lee Rudow | PSU | 3,925 | — | 279,931 |
| Michael West | RSU | 2,000 | — | 142,640 |
| Thomas Barbato | PSU | 1,186 | — | 84,586 |
| Theresa Conroy | PSU | 524 | — | 37,372 |
| Michael West | RSU | 916 | — | 65,329 |
| Michael Haddad | PSU | 730 | — | 52,064 |
Our compensation program is designed to attract, motivate and retain a highly-qualified and effective executive management team. We believe that the most effective executive compensation program is one that is designed to reward the achievement of specific annual, long-term and strategic company goals, which aligns the interests of each of our executive management team with those of our shareholders.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Company, Inc. |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | False |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-09-10 | 7,842,250 | 75,934 | 4,704 | 99.04% | Passed |
| 2024 | 2024-09-11 | 7,850,677 | 252,100 | 26,084 | 96.89% | Passed |
| 2023 | 2023-09-06 | 6,603,935 | 119,485 | 17,142 | 98.22% | Passed |
| 2022 | 2022-09-07 | 5,909,671 | 36,551 | 27,750 | 99.39% | Passed |
| 2021 | 2021-09-08 | 6,164,404 | 168,557 | 15,058 | 97.34% | Passed |
| 2020 | 2020-09-09 | 5,331,412 | 73,616 | 106,597 | 98.64% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-09-10 | 99.04%a |
| 2024 | 2024-09-11 | 96.89%b |
| 2023 | 2023-09-06 | 98.22%c |
a. Approved under the standard stated in the filing — “Thus, abstentions will have no effect on the outcome of the vote on the proposals requiring the approval of a plurality or a majority of votes duly cast (Proposals One, Three, Four, and Five), because abstentions are not counted as votes duly cast.”.
b. Approved under the standard stated in the filing — “Thus, abstentions will have no effect on the outcome of the vote on the proposals requiring the approval of a plurality or a majority of votes duly cast (Proposals One, Two and Three), because abstentions are not counted as votes duly cast.”.
c. Approved under the standard stated in the filing — “Thus, abstentions will have no effect on the outcome of the vote on the proposals requiring the approval of a plurality or a majority of votes duly cast (Proposals One, Two and Three), because abstentions are not counted as votes duly cast.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 87 : 1 |
|---|---|
| CEO total compensation | $5,862,200 |
| Median employee compensation | $67,600 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Gary J. HaseleyIndependent · Board Chair · Executive (Chair) | $135,000 | $120,009 | $0 | — | $0 | $255,009 |
| Mbago M. KanikiIndependent · Audit · Executive · NESG (Chair) | 105,000 | 120,009 | 0 | — | 0 | 225,009 |
| Oksana S. DominachIndependent · Audit (Chair) · Compensation · Executive | 95,000 | 120,009 | 0 | — | 0 | 215,009 |
| Cynthia M. LangstonIndependent · Audit · Technology (Chair) | 70,000 | 120,009 | 0 | — | 0 | 190,009 |
| Craig D. CairnsIndependent · Compensation (Chair) | 70,000 | 120,009 | 0 | — | 0 | 190,009 |
| Dawn G. DePerriorIndependent · Compensation · NESG · Technology | 60,625 | 120,009 | 0 | — | 0 | 180,634 |
| Christopher P. GilletteIndependent · Compensation · NESG · Technology | 60,625 | 120,009 | 0 | — | 0 | 180,634 |
| Robert L. MeccaIndependent · Audit | 55,000 | 120,009 | 0 | — | 0 | 175,009 |
| Charles P. HadeedIndependent · Audit · Executive · Not standing for re-election · Departed during FY | 24,375 | — | 0 | — | 0 | 24,375 |
| Jaime A. IrickEmployee director · Partial-year service · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $55,000 |
|---|---|
| Annual equity retainer | $120,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 |
| Stock ownership guideline | 3.0x annual cash retainer |
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $675,625 |
| Equity awards (grant-date value) | $960,072 |
| All other compensation | $0 |
| Total cost of the board | $1,635,697 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Transcat names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Transcat.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | AeroVironment, Inc. | 2026 | Wahid Nawabi | $1,118,829 | $13,339,715 | $0 | $767,609 | $15,253,775 |
| 2 | Ligand Pharmaceuticals Incorporated | 2025 | Todd Davis | 724,500 | 5,520,493 | 4,441,120 | 764,400 | 11,472,095 |
| 3 | Axsome Therapeutics, Inc. | 2025 | Herriot Tabuteau | 835,000 | 5,533,554 | 2,833,237 | 876,750 | 10,283,492 |
| 4 | Mesa Laboratories, Inc. | 2026 | Gary Owens | 808,846 | 4,700,017 | 0 | 1,120,000 | 6,643,208 |
| 5 | Transcat | 2026 | Lee Rudow | 737,000 | 4,613,932 | 0 | 494,115 | 5,862,200 |
| 6 | Cytek Biosciences, Inc. | 2025 | Wenbin Jiang | 620,000 | 2,000,000 | 2,000,000 | 485,211 | 5,120,061 |
| 7 | Standex International Corporation | 2025 | David Dunbar | 936,436 | 3,553,548 | 0 | 339,224 | 5,117,281 |
| 8 | LeMaitre Vascular, Inc. | 2025 | George LeMaitre | 806,347 | 1,050,000 | 1,050,000 | 680,015 | 3,780,990 |
| 9 | Surmodics, Inc. | 2024 | Gary Maharaj | 647,481 | 940,000 | 1,410,000 | 654,215 | 3,665,496 |
| 10 | Powell Industries, Inc. | 2025 | Brett Cope | 660,000 | 1,129,268 | 0 | 1,650,000 | 3,600,369 |
| 11 | Tactile Systems Technology, Inc. | 2025 | Sheri Dodd | 675,000 | 2,019,978 | 0 | 737,438 | 3,466,916 |
| 12 | Cryoport, Inc. | 2025 | Jerrell Shelton | 967,845 | 192,300 | 306,869 | 908,510 | 2,375,524 |
| — | Graham Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Ducommun Incorporated | — | — | — | — | — | — | not in coverage universe |
| — | Argan, Inc. | — | — | — | — | — | — | not in coverage universe |
| — | Willis Lease Finance Corporation | — | — | — | — | — | — | not in coverage universe |
| — | Omega Flex, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Transcat | 67% | PSU 50 · RSU 50 | No | Frederic W. Cook & Company, Inc. |
| AeroVironment, Inc. | 62% | PSU 65 · RSU 35 | No | Pay Governance |
| Argan, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Axsome Therapeutics, Inc. | 150% | RSU 33 · Options 33 · PSU 33 | No | Frederic W. Cook & Co., Inc. |
| Cryoport, Inc. | 92.2% | Options 62 · RSU 38 | not disclosed | Frederic W. Cook & Co., Inc. |
| Cytek Biosciences, Inc. | 78.4% | RSU 50 · Options 50 | not disclosed | Meridian Compensation Partners, LLC |
| Ducommun Incorporated | not disclosed | not disclosed | not disclosed | not disclosed |
| Graham Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
| LeMaitre Vascular, Inc. | 144% | Options 50 · RSU 25 · PSU 25 | No | not disclosed |
| Ligand Pharmaceuticals Incorporated | 150% | Options 44 · PSU 31 · RSU 25 | No | Aon (Talent Solutions practice) |
| Mesa Laboratories, Inc. | 125% | PSU 50 · RSU 50 | No | Frederic W. Cook & Co, Inc. |
| Omega Flex, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Powell Industries, Inc. | 200% | PSU 50 · RSU 50 | No | not disclosed |
| Standex International Corporation | 69.0% | PSU 60 · RSU 40 | Yes — Relative TSR | Independent compensation consultant |
| Surmodics, Inc. | 126.3% | Options 60 · RSU 40 | not disclosed | Pay Governance LLC |
| Tactile Systems Technology, Inc. | 115% | PSU 50 · RSU 50 | No | Aon Consulting, Inc. |
| Willis Lease Finance Corporation | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Lee Rudow | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “2026 Summary Compensation Table”. As printed: 5,862,200. Filing ↗machine: r2 · c18 · span 633269–633278 |
| 2 | Section 01, Thomas Barbato | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “2026 Summary Compensation Table”. As printed: 2,235,400. Filing ↗machine: r5 · c18 · span 643442–643451 |
| 3 | Section 01, Michael West | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “2026 Summary Compensation Table”. As printed: 1,438,546. Filing ↗machine: r13 · c18 · span 671192–671201 |
| 4 | Section 01, Theresa Conroy | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “2026 Summary Compensation Table”. As printed: 1,236,590. Filing ↗machine: r8 · c18 · span 653497–653506 |
| 5 | Section 01, Michael Haddad | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “2026 Summary Compensation Table”. As printed: 907,513. Filing ↗machine: r11 · c18 · span 664105–664112 |
| 6 | Section 03, Michael Haddad RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t84 · r6 · c12 · span 595807–595812 |
| 7 | Section 03, Theresa Conroy RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t84 · r5 · c12 · span 593457–593463 |
| 8 | Section 03, Lee Rudow RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r4 · c28 · span 725108–725117 |
| 9 | Section 03, Michael West RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t84 · r7 · c12 · span 598359–598365 |
| 10 | Section 03, Lee Rudow RSU | DEF 14A | — | 0001140361-26-029371 | Section “TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t106 · r10 · c19 · span 887273–887279 |
| 11 | Section 03, Lee Rudow PSU | DEF 14A | — | 0001140361-26-029371 | Section “TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. Filing ↗machine: t106 · r10 · c19 · span 887273–887279 |
| 12 | Section 03, Theresa Conroy PSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r13 · c28 · span 772668–772675 |
| 13 | Section 03, Thomas Barbato RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t84 · r4 · c12 · span 590789–590795 |
| 14 | Section 03, Michael West RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r21 · c28 · span 815074–815081 |
| 15 | Section 03, Thomas Barbato RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r10 · c28 · span 756069–756076 |
| 16 | Section 03, Michael West PSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r21 · c28 · span 815074–815081 |
| 17 | Section 03, Thomas Barbato PSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r9 · c28 · span 751555–751562 |
| 18 | Section 03, Michael Haddad RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r18 · c28 · span 798461–798467 |
| 19 | Section 03, Michael Haddad PSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r17 · c28 · span 793947–793953 |
| 20 | Section 03, Theresa Conroy RSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r13 · c28 · span 772668–772675 |
| 21 | Section 03, Lee Rudow PSU | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t98 · r4 · c28 · span 725108–725117 |
| 22 | Section 07, pay ratio | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “CEO Pay Ratio”. As printed: 87 : 1. Filing ↗machine: span 1191429–1191436 |
| 23 | Section 08, Gary J. Haseley | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 255,009. Filing ↗machine: t143 · r7 · c9 · span 1345259–1345266 |
| 24 | Section 08, Mbago M. Kaniki | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 225,009. Filing ↗machine: t143 · r8 · c9 · span 1347255–1347262 |
| 25 | Section 08, Oksana S. Dominach | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 215,009. Filing ↗machine: t143 · r4 · c9 · span 1339626–1339633 |
| 26 | Section 08, Cynthia M. Langston | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 190,009. Filing ↗machine: t143 · r9 · c9 · span 1349024–1349031 |
| 27 | Section 08, Craig D. Cairns | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 190,009. Filing ↗machine: t143 · r2 · c9 · span 1335821–1335828 |
| 28 | Section 08, Dawn G. DePerrior | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 180,634. Filing ↗machine: t143 · r3 · c9 · span 1337588–1337595 |
| 29 | Section 08, Christopher P. Gillette | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 180,634. Filing ↗machine: t143 · r5 · c9 · span 1341399–1341406 |
| 30 | Section 08, Robert L. Mecca | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 175,009. Filing ↗machine: t143 · r10 · c9 · span 1350963–1350970 |
| 31 | Section 08, Charles P. Hadeed | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 24,375. Filing ↗machine: t143 · r6 · c3 · span 1342342–1342348 |
| 32 | Section 08, Jaime A. Irick | DEF 14A | 2026-07-23 | 0001140361-26-029371 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 33 | Section 06, 2025 vote | Form 8-K | 2025-09-11 | 0001206774-25-000682 | Item 5.07 · say-on-pay result. As reported: 99.04% (votes for as printed: 7,842,250). Filing ↗ |
| 34 | Section 06, 2024 vote | Form 8-K | 2024-09-13 | 0001206774-24-000898 | Item 5.07 · say-on-pay result. As reported: 96.89% (votes for as printed: 7,850,677). Filing ↗ |
| 35 | Section 06, 2023 vote | Form 8-K | 2023-09-07 | 0001206774-23-001124 | Item 5.07 · say-on-pay result. As reported: 98.22% (votes for as printed: 6,603,935). Filing ↗ |
| 36 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 37 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 38 | Section 09b board cost (computed) | Computed | — | computed | Cash 675,625 + equity 960,072 + all other 0 = 1,635,697, summed across the director compensation table rows.machine: formula: Σ = 1,635,697 |
| 39 | AeroVironment, Inc., Section 10b CEO total | DEF 14A | 2026-08-14 | 0001104659-26-096689 | CEO total compensation as printed in AeroVironment, Inc.'s own proxy. As printed: 15,253,775. Filing ↗machine: t127 · r1 · c42 · span 1424713–1424723 |
| 40 | Ligand Pharmaceuticals Incorporated, Section 10b CEO total | DEF 14A | 2026-04-21 | 0000886163-26-000021 | CEO total compensation as printed in Ligand Pharmaceuticals Incorporated's own proxy. As printed: 11,472,095. Filing ↗machine: span 722741–722751 |
| 41 | Axsome Therapeutics, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001193125-26-177610 | CEO total compensation as printed in Axsome Therapeutics, Inc.'s own proxy. As printed: 10,283,492. Filing ↗machine: t51 · r2 · c27 · span 900236–900246 |
| 42 | Mesa Laboratories, Inc., Section 10b CEO total | DEF 14A | 2026-07-22 | 0000724004-26-000071 | CEO total compensation as printed in Mesa Laboratories, Inc.'s own proxy. As printed: 6,643,208. Filing ↗machine: r3 · c24 · span 580946–580955 |
| 43 | Transcat (subject), Section 10b CEO total | DEF 14A | 2026-07-23 | 0001140361-26-029371 | CEO total compensation as printed in Transcat's own proxy. As printed: 5,862,200. Filing ↗machine: r2 · c18 · span 633269–633278 |
| 44 | Cytek Biosciences, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001140361-26-017479 | CEO total compensation as printed in Cytek Biosciences, Inc.'s own proxy. As printed: 5,120,061. Filing ↗machine: r2 · c21 · span 561243–561252 |
| 45 | Standex International Corporation, Section 10b CEO total | DEF 14A | 2025-09-05 | 0001437749-25-028442 | CEO total compensation as printed in Standex International Corporation's own proxy. As printed: 5,117,281. Filing ↗machine: t217 · r1 · c28 · span 1012679–1012688 |
| 46 | LeMaitre Vascular, Inc., Section 10b CEO total | DEF 14A | 2026-04-14 | 0001193125-26-153877 | CEO total compensation as printed in LeMaitre Vascular, Inc.'s own proxy. As printed: 3,780,990. Filing ↗machine: span 564038–564047 |
| 47 | Surmodics, Inc., Section 10b CEO total | DEF 14A | 2024-12-19 | 0000950170-24-138240 | CEO total compensation as printed in Surmodics, Inc.'s own proxy. As printed: 3,665,496. Filing ↗machine: t109 · r3 · c25 · span 1568790–1568799 |
| 48 | Powell Industries, Inc., Section 10b CEO total | DEF 14A | 2026-01-06 | 0001140361-26-000342 | CEO total compensation as printed in Powell Industries, Inc.'s own proxy. As printed: 3,600,369. Filing ↗machine: r2 · c27 · span 542584–542594 |
| 49 | Tactile Systems Technology, Inc., Section 10b CEO total | DEF 14A | 2026-03-25 | 0001104659-26-034206 | CEO total compensation as printed in Tactile Systems Technology, Inc.'s own proxy. As printed: 3,466,916. Filing ↗machine: r3 · c12 · span 865797–865806 |
| 50 | Cryoport, Inc., Section 10b CEO total | DEF 14A | 2026-04-22 | 0001140361-26-016129 | CEO total compensation as printed in Cryoport, Inc.'s own proxy. As printed: 2,375,524. Filing ↗machine: t277 · r2 · c22 · span 1285130–1285139 |
| 51 | Section 10a, Powell Industries, Inc. reciprocity | DEF 14A | — | 0001140361-26-000342 | Powell Industries, Inc.'s most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |
| 52 | Section 10a, Cytek Biosciences, Inc. reciprocity | DEF 14A | — | 0001140361-26-017479 | Cytek Biosciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |
| 53 | Section 10a, Mesa Laboratories, Inc. reciprocity | DEF 14A | — | 0000724004-26-000071 | Mesa Laboratories, Inc.'s most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |
| 54 | Section 10a, Tactile Systems Technology, Inc. reciprocity | DEF 14A | — | 0001104659-26-034206 | Tactile Systems Technology, Inc.'s most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |
| 55 | Section 10a, Axsome Therapeutics, Inc. reciprocity | DEF 14A | — | 0001193125-26-177610 | Axsome Therapeutics, Inc.'s most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |
| 56 | Section 10a, Ligand Pharmaceuticals Incorporated reciprocity | DEF 14A | — | 0000886163-26-000021 | Ligand Pharmaceuticals Incorporated's most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |
| 57 | Section 10a, Surmodics, Inc. reciprocity | DEF 14A | — | 0000950170-24-138240 | Surmodics, Inc.'s most recent proxy was read; its disclosed peer group does not include Transcat. Filing ↗ |